Korean J Anesthesiol.
2013 Dec;65(6):495-500. 10.4097/kjae.2013.65.6.495.
Sugammadex: clinical development and practical use
- Affiliations
-
- 1Department of Anesthesiology, Centre Hospitalier Universitaire de NANCY, Hopital de Brabois, Vandoeuvre, France. t.fuchs-buder@chu-nancy.fr
- KMID: 2092374
- DOI: http://doi.org/10.4097/kjae.2013.65.6.495
Abstract
- Sugammadex is belonging to a new class of drugs: the selective relaxant binding agents. Sugammadex can reverse residual paralysis by encapsulating free circulating non depolarizing muscle relaxants. The mains advantages of sugammadex when compared with conventional anticholinesterase agents are a much faster recovery time and the unique ability, for the first time, to reverse rapidly and efficiently deep levels of neuromuscular blockade. However it only works for reversal of rocuronium or vecuronium-induced neuromuscular blockade. When administered 3 min after rocuronium the use of a large dose (16 mg/kg) can even reverse rocuronium significantly faster than the spontaneous recovery after succinylcholine.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
- Advantages and pitfalls of clinical application of sugammadex
- Clinical use of sugammadex
- The potential risks of sugammadex
- What we need to know and do on sugammadex usage in pregnant and lactating women and those on hormonal contraceptives
